Research Associate - Process Research & Development 2
About the job
- A Bachelor of Science or Master of Science degree in Chemistry, Chemical Engineering, or Biochemistry.
- Knowledge of and hands-on experience in organic and polymer chemistry.
- Industry research and development experience in one or more of the following areas: organic small-molecule synthesis; automated DNA or peptide synthesis; use of instrumentation for chemical and spectroscopic analysis such as liquid chromatography, mass spectrometry, high-performance liquid chromatography, nuclear magnetic resonance, Fourier-transform infrared spectroscopy, ultraviolet analysis, or fluorescence; basic cleanroom or microfabrication processing technologies.
- Demonstrated ability to plan and execute research experiments.
- Ability to develop additional competencies and apply practical skills and knowledge to solving applied scientific and technical problems.
- Conduct supervised research to develop new reagents, materials, and processes for new manufacturing technologies.
- Perform organic synthesis.
- Conduct instrumental chemical analysis to evaluate the performance of components and processes.
- Document experimental work, analyze data, and document and present results.
- Prepare written methods and standard operating procedures.
- Calibrate and maintain analytical instruments, process tools, and systems.
- Procure components, materials, and reagents.
- Support research and development, manufacturing pilot, and quality control operations.
About the company
Centrillion Technologies develops tools for genomic studies, including sequencing, bioinformatics, and a new generation of DNA chips designed for high-density, high-quality probes that work with sequencing. Its products include ATOM, a high-throughput detection system, and VirusHunter MVP, a pathogen-detection assay, along with sequencing and droplet digital PCR services for researchers and drug discovery groups. It differentiates itself by offering integrated genomics hardware, assays, and services with DNA chips optimized for large-scale analysis that complement sequencing workflows. Its goal is to enable broad, scalable genomic studies to accelerate drug discovery, personalized medicine, and molecular diagnostics.
Company Size
51-200
Company Stage
Series B
Total Funding
$24.3M
Headquarters
Palo Alto, California
Founded
2009
Get referred to Centrillion Technologies
See people who can refer or advise you
Simplify's Take
What believers are saying
- September 2026 site updates show active product marketing and service availability.
- Centrillion’s August 2026 AI messaging targets genome, cell, and tissue data buyers.
- The platform keeps multiple revenue paths: research chips, diagnostics, and sequencing services.
What critics are saying
- VirusHunter MVP remains only through Molecular Vision Laboratories as of August 2026.
- Centrillion shows no fresh 2025-2026 financing, suggesting constrained commercial scale.
- Illumina, Thermo Fisher, and Oxford Nanopore can crush adoption if chip volumes lag.
What makes Centrillion Technologies unique
- Centrillion’s September 2026 chips combine 50,000-2 million variants with sequencing workflows.
- VirusHunter pairs pathogen detection and whole-genome sequencing on ATOM and QuadCore chips.
- The company still owns a rare integrated stack: chips, assays, and clinical-lab services.
Help us improve and share your feedback! Did you find this helpful?